Skip to content

Clinical trials

Recruiting Lymphoma, B-Cell, Marginal Zone trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Recruiting Country / region: Italy Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20212
20221
20233
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
BeOne Medicines1
Eli Lilly and Company1
Enterome1
International Extranodal Lymphoma Study Group (IELSG)1
Nurix Therapeutics, Inc.1
Regeneron Pharmaceuticals1
Schrödinger, Inc.1
Taiho Oncology, Inc.1
The Lymphoma Academic Research Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone11
Lymphoma, Follicular7
Lymphoma, Mantle-Cell5
Waldenstrom Macroglobulinemia5
Lymphoma, Large B-Cell, Diffuse4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Non-Hodgkin3
Lymphoma, B-Cell2
Burkitt Lymphoma1
Lymphoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.